'%20d='m0%200%2016%2011h61%2061%2061%2061%2060L47%2037h61%2061%2060%2061L16%2063h61%2061%2061%2061%2060L47%2089h61%2061%2060%2061L16%20115h61%2061%2061%2061%2060L47%20141h61%2061%2060%2061L16%20166h61%2061%2061%2061%2060L47%20192h61%2061%2060%2061L16%20218h61%2061%2061%2061%2060z'/%3e%3c/svg%3e)
About
Dr. Carrie Wambach went into reproductive medicine to preserve the fertility of cancer patients, and stayed for the rest of the field. Her named focus now sits in three of the harder corners of it: recurrent miscarriage, premature ovarian failure, and reproductive immunology — the study of immune and clotting dysfunction as a cause of implantation failure and loss. She publishes in reproductive immunology journals, which is a small enough literature that the interest is verifiable rather than decorative.
Her credentials come through California programs at every stage but the first: a bachelor’s in the College of Literature, Science & the Arts at Michigan, an MD from UC Irvine College of Medicine in 2008, UCLA obstetrics and gynecology residency in 2012, and a three-year UCLA Reproductive Endocrinology and Infertility fellowship completed in 2015. She holds board certification in both obstetrics and gynecology and reproductive endocrinology and infertility, and treats at the Beverly Hills campus of Reproductive Partners Medical Group. Her peers nominated her as a 2024 Los Angeles Magazine Super Doctor and she is listed in Castle Connolly’s Top Doctors for the same year.
The third fact about her is the one patients repeat. Wambach went through infertility treatment herself and became a mother through it — her two sons were conceived after the same kind of workup, stimulation and transfer she now prescribes. That is a different vantage point in a consultation about a failed cycle. In one of the practice’s published patient stories, a mother with PCOS and a BRCA2 mutation describes Wambach taking her through a custom PGT probe and both PGT-A and PGT-M to select an embryo that did not carry the mutation — the intersection of genetic risk and loss prevention where her focus sits.
Clinical Expertise
- Recurrent pregnancy loss evaluation: testing for chromosomal abnormalities in either partner, uterine structural causes such as fibroids, polyps, scar tissue or a septum, progesterone support, and thyroid, diabetes, immune and clotting disorders, offered after two losses before 20 weeks or one after
- Reproductive immunology: her published research area, applied to implantation failure and loss where an inflammatory or clotting contribution is suspected
- Premature ovarian insufficiency and diminished reserve: stimulation design for patients with low egg supply, and counseling about what reserve numbers do and do not predict
- Fertility preservation for oncology patients: the reason she entered the specialty; egg, embryo and ovarian tissue freezing ahead of gonadotoxic treatment, coordinated with the treating oncologist’s timeline
- IVF with PGT-M and PGT-A: embryo biopsy at the blastocyst stage, with samples shipped to an outside genetics laboratory, for known single-gene conditions and chromosome-number screening
- Hysteroscopic correction of uterine factors: structural problems identified in a loss workup treated before the next transfer attempt
Why Choose Dr. Carrie Wambach
She holds both certifications. ABOG certification in obstetrics and gynecology and in reproductive endocrinology and infertility — the two-exam route most US reproductive endocrinologists take, and the one that lets her handle the surgical as well as the medical side of a loss workup.
A named research niche, not a generalist listing. Reproductive immunology is where a lot of “unexplained” recurrent loss quietly lives, and she publishes in it.
She has been the patient. Her own path to her sons through infertility treatment is the reason her style is described as explaining probabilities rather than offering reassurance.
Recognized in 2024 by both physician-nominated lists her patients will see cited — Los Angeles Magazine Super Doctor and Castle Connolly Top Doctors.
Professional Affiliations
Board-certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility by the American Board of Obstetrics and Gynecology. UCLA residency and fellowship training. American College of Obstetricians and Gynecologists and American Society for Reproductive Medicine are the standard societies for this specialty; her published work appears in reproductive immunology literature. On staff at Reproductive Partners Medical Group, a SART-member practice (clinic ID 2254) whose CAP-accredited laboratory performs embryo biopsy in house and sends genetic samples to an outside PGT laboratory.
Suitable For
- Two or more miscarriages, or a loss after 20 weeks: a structured evaluation rather than another attempt
- A BRCA or other known familial mutation: PGT-M cycles designed to avoid transmitting it
- Diminished ovarian reserve or early menopause, including patients told their numbers were the end of the conversation
- Cancer patients starting treatment: egg, embryo or tissue freezing on an oncology deadline
- Women over 35 planning IVF who want the immune and clotting possibilities addressed alongside age and reserve